GlassScriptPhysician profile
Michelle Figueroa
NPI 1629669700
$3,739.84
in general payments reported to CMS, 2019-2025
23 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,405 · 2024: $1,981 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,693 · Education: $46.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,692.93 |
| Education | $46.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $760.69 | 2023-2025 | Fanapt, Hetlioz |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $699.24 | 2023-2025 | Caplyta |
| Abbvie INC. | $504.99 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $382.47 | 2023-2024 | Spravato, Xarelto |
| Axsome Therapeutics, INC. | $289.20 | 2024-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $213.83 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $179.70 | 2023-2024 | Cologuard Collection Kit |
| Corium, LLC | $141.16 | 2023-2024 | Azstarys |
| Lundbeck LLC | $140.92 | 2024-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.28 | 2023-2024 | Jardiance, Tradjenta, Synjardy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.74 | 2023-2024 | Xifaxan |
| Merck Sharp & Dohme LLC | $45.96 | 2023-2024 | Verquvo, Belsomra |
| Bayer Healthcare Pharmaceuticals INC. | $35.51 | 2023 | |
| Esperion Therapeutics, INC. | $32.99 | 2023-2024 | Nexletol |
| Phathom Pharmaceuticals, INC. | $31.04 | 2024 | Voquezna |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $28.85 | 2024 | Korlym |
| Kyowa Kirin, INC. | $26.71 | 2024 | Crysvita |
| Paratek Pharmaceuticals, INC. | $19.21 | 2024 | Nuzyra |
| Phadia US INC. | $17.54 | 2023 | Immunocap |
| Novo Nordisk INC | $15.75 | 2023 | |
| Philips North America LLC | $14.55 | 2024 | (Ck4) Mcot |
| Idorsia Pharmaceuticals US INC | $14.28 | 2023 | Quviviq |
| Ironshore Pharmaceuticals INC. | $14.23 | 2023 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Figueroa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.